For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240216:nRSP4979Da&default-theme=true
RNS Number : 4979D Wells Fargo Bank N.A. 16 February 2024
Publication of Pricing Supplement
The pricing supplement of Wells Fargo Bank, National Association dated 8
February 2024 (the "Pricing Supplement") for the issue of U.S.$20,000,000 zero
coupon callable notes due 16 February 2034 (ISIN XS2764433053) under its
U.S.$10,000,000,000 euro medium term note programme is available for viewing.
To view the full document, please paste the following URL into the address bar
of your browser:
http://www.rns-pdf.londonstockexchange.com/rns/4979D_1-2024-2-16.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/4979D_1-2024-2-16.pdf)
For further information, please contact
Sandra Galvis
Senior Lead Counsel & Executive Director
Wells Fargo & Company
sandra.j.galvis@wellsfargo.com
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Pricing Supplement and/or
the information memorandum dated 18 September 2023 relating to the
above-mentioned programme (as supplemented, the "Information Memorandum") may
be addressed to and/or targeted at persons who are residents of particular
countries (specified in the Pricing Supplement and/or the Information
Memorandum) only and is not intended for use and should not be relied upon by
any person outside these countries and/or to whom the offer contained in the
Pricing Supplement and/or the Information Memorandum is not addressed. Prior
to relying on the information contained in the Pricing Supplement and/or the
Information Memorandum you must ascertain from the Pricing Supplement and/or
the Information Memorandum whether or not you are part of the intended
addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above
requirement.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END PSPUNAVRSRUUAAR